107
Views
4
CrossRef citations to date
0
Altmetric
Back-to-back stimulation cycles with OC or Progestins in women undergoing Embryo accumulation

Linking back-to-back stimulation cycles with oral contraceptives or progestins in women undergoing embryo accumulation for preimplantation genetic testing, a retrospective study

ORCID Icon, , , , , , & ORCID Icon show all
Pages 955-960 | Received 15 Jan 2018, Accepted 02 May 2018, Published online: 17 May 2018

References

  • Rubio C, Bellver J, Rodrigo L, et al. In vitro fertilization with preimplantation genetic diagnosis for aneuploidies in advanced maternal age: a randomized, controlled study. Fertil Steril. 2017;107:1122–1129.
  • De Rycke M, Belva F, Goossens V, et al. ESHRE PGD consortium data collection XIII: cycles from January to December 2010 with pregnancy follow-up to October 2011. Hum Reprod. 2015;30:1763–1789.
  • Ata B, Kaplan B, Danzer H, et al. Array CGH analysis shows that aneuploidy is not related to the number of embryos generated. Reprod Biomed Online. 2012;24:614–620.
  • Jabbour HN, Kelly RW, Fraser HM, Critchley HOD. Endocrine regulation of menstruation. Endocr Rev. 2006;27:17–46.
  • Maybin JA, Critchley HOD. Menstrual physiology: implications for endometrial pathology and beyond. Hum Reprod Update. 2015;21:748–761.
  • Nippoldt TB, Reame NE, Kelch RP, Marshall JC. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle. J Clin Endocrinol Metab. 1989;69:67–76.
  • Humaidan P, Nelson SM, Devroey P, et al. Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials. Hum Reprod. 2016;31:1997–2004.
  • Veiga A, Sandalinas M, Benkhalifa M, et al. Laser blastocyst biopsy for preimplantation diagnosis in the human. Zygote Camb Engl. 1997;5:351–354.
  • Practice Committee of the American Society for Reproductive Medicine. Endometriosis and infertility: a committee opinion. Fertil Steril. 2012;98:591–598.
  • Jia XC, Kessel B, Yen SS, et al. Serum bioactive follicle-stimulating hormone during the human menstrual cycle and in hyper- and hypogonadotropic states: application of a sensitive granulosa cell aromatase bioassay. J Clin Endocrinol Metab. 1986;62:1243–1249.
  • Roseff SJ, Bangah ML, Kettel LM, et al. Dynamic changes in circulating inhibin levels during the luteal-follicular transition of the human menstrual cycle. J Clin Endocrinol Metab. 1989;69:1033–1039.
  • Schneyer AL, Sluss PM, Whitcomb RW, et al. Development of a radioligand receptor assay for measuring follitropin in serum: application to premature ovarian failure. Clin Chem. 1991;37:508–514.
  • Christin-Maitre S, Taylor AE, Khoury RH, et al. Homologous in vitro bioassay for follicle-stimulating hormone (FSH) reveals increased FSH biological signal during the mid- to late luteal phase of the human menstrual cycle. J Clin Endocrinol Metab. 1996;81:2080–2088.
  • Yen SS, Tsai CC, Naftolin F, et al. Pulsatile patterns of gonadotropin release in subjects with and without ovarian function. J Clin Endocrinol Metab. 1972;34:671–675.
  • Bäckström CT, McNeilly AS, Leask RM, Baird DT. Pulsatile secretion of LH, FSH, prolactin, oestradiol and progesterone during the human menstrual cycle. Clin Endocrinol (Oxf). 1982;17:29–42.
  • Marshall JC, Kelch RP. Gonadotropin-releasing hormone: role of pulsatile secretion in the regulation of reproduction. N Engl J Med. 1986;315:1459–1468.
  • Cohen BL, Katz M. Pituitary and ovarian function in women receiving hormonal contraception. Contraception. 1979;20:475–487.
  • Wulff C, Wilson H, Largue P, et al. Angiogenesis in the human corpus luteum: localization and changes in angiopoietins, tie-2, and vascular endothelial growth factor messenger ribonucleic acid. J Clin Endocrinol Metab. 2000;85:4302–4309.
  • Fraser HM, Wilson H, Wulff C, et al. Administration of vascular endothelial growth factor Trap during the “post-angiogenic” period of the luteal phase causes rapid functional luteolysis and selective endothelial cell death in the marmoset. Reprod Camb Engl. 2006;132:589–600.
  • Garcia-Velasco JA, Bermejo A, Ruiz F, et al. Cycle scheduling with oral contraceptive pills in the GnRH antagonist protocol vs the long protocol: a randomized, controlled trial. Fertil Steril. 2011;96:590–593.
  • Martin JR, Mahutte NG, Arici A, Sakkas D. Impact of duration and dose of gonadotrophins on IVF outcomes. Reprod Biomed Online. 2006;13:645–650.
  • Check JH, Katsoff B, Brasile D, et al. The effect of length of the follicular phase on pregnancy outcome following single embryo transfer (ET) in hypergonadotropic women. Clin Exp Obstet Gynecol. 2009;36:76–77.
  • Rombauts L, Suikkari AM, MacLachlan V, et al. Recruitment of follicles by recombinant human follicle-stimulating hormone commencing in the luteal phase of the ovarian cycle. Fertil Steril. 1998;69:665–669.
  • Letourneau JM, Sinha N, Wald K, et al. Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer. Hum Reprod Oxf Engl. 2017;32:2123–2129.
  • Ubaldi FM, Capalbo A, Vaiarelli A, et al. Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: new insight in ovarian reserve exploitation. Fertil Steril. 2016;105:1488–1495.e1.
  • Altman DG, Bland JM. Absence of evidence is not evidence of absence. BMJ. 1995;311:485.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.